Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flortaucipir PET Imaging in BIOCARD
NCT03052972Phase 1Terminated
- Sponsor
- Avid Radiopharmaceuticals
- Start
- Mar 2017
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of flortaucipir in Alzheimer's disease (AD) (2 arms), sponsored by Avid Radiopharmaceuticals. Primary endpoints: Qualitative Evaluation of Scan Results and Quantitative Evaluation of Scan Results. Started Mar 2017; status: terminated.
02
Drugs
flortaucipir
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT03052972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03052972.